2127 related articles for article (PubMed ID: 14973191)
21. Chronic lymphocytic leukemia and 13q14: miRs and more.
Mertens D; Philippen A; Ruppel M; Allegra D; Bhattacharya N; Tschuch C; Wolf S; Idler I; Zenz T; Stilgenbauer S
Leuk Lymphoma; 2009 Mar; 50(3):502-5. PubMed ID: 19347735
[TBL] [Abstract][Full Text] [Related]
22. Common fragile sites.
Arlt MF; Casper AM; Glover TW
Cytogenet Genome Res; 2003; 100(1-4):92-100. PubMed ID: 14526169
[TBL] [Abstract][Full Text] [Related]
23. A selected group of large common fragile site genes have decreased expression in oropharyngeal squamous cell carcinomas.
Gao G; Kasperbauer JL; Tombers NM; Wang V; Mayer K; Smith DI
Genes Chromosomes Cancer; 2014 May; 53(5):392-401. PubMed ID: 24481768
[TBL] [Abstract][Full Text] [Related]
24. Chromosome fragile sites.
Durkin SG; Glover TW
Annu Rev Genet; 2007; 41():169-92. PubMed ID: 17608616
[TBL] [Abstract][Full Text] [Related]
25. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
27. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
28. Common fragile sites and cancer: targeted cloning by insertional mutagenesis.
Büttel I; Fechter A; Schwab M
Ann N Y Acad Sci; 2004 Dec; 1028():14-27. PubMed ID: 15650228
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2.
Bazot Q; Paschos K; Skalska L; Kalchschmidt JS; Parker GA; Allday MJ
PLoS Pathog; 2015 Jul; 11(7):e1005031. PubMed ID: 26153983
[TBL] [Abstract][Full Text] [Related]
30. The oncological relevance of fragile sites in cancer.
Simpson BS; Pye H; Whitaker HC
Commun Biol; 2021 May; 4(1):567. PubMed ID: 33980983
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
Nana-Sinkam SP; Croce CM
Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
[TBL] [Abstract][Full Text] [Related]
32. Biallelic deletion and loss of expression analysis of genes at FRA2G common fragile site in tumor-derived cell lines.
Limongi ZM; Curatolo A; Pelliccia F; Rocchi A
Cancer Genet Cytogenet; 2005 Sep; 161(2):181-6. PubMed ID: 16102592
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations.
Starczynowski DT; Morin R; McPherson A; Lam J; Chari R; Wegrzyn J; Kuchenbauer F; Hirst M; Tohyama K; Humphries RK; Lam WL; Marra M; Karsan A
Blood; 2011 Jan; 117(2):595-607. PubMed ID: 20962326
[TBL] [Abstract][Full Text] [Related]
34. Mammalian microRNAs: a small world for fine-tuning gene expression.
Sevignani C; Calin GA; Siracusa LD; Croce CM
Mamm Genome; 2006 Mar; 17(3):189-202. PubMed ID: 16518686
[TBL] [Abstract][Full Text] [Related]
35. The miR-15a/16 gene cluster in human cancer: A systematic review.
Liu T; Xu Z; Ou D; Liu J; Zhang J
J Cell Physiol; 2019 May; 234(5):5496-5506. PubMed ID: 30246332
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of the human common fragile site FRA1H.
Curatolo A; Limongi ZM; Pelliccia F; Rocchi A
Genes Chromosomes Cancer; 2007 May; 46(5):487-93. PubMed ID: 17311248
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
Li F; Xu Y; Deng S; Li Z; Zou D; Yi S; Sui W; Hao M; Qiu L
Oncotarget; 2015 Nov; 6(35):38270-82. PubMed ID: 26516702
[TBL] [Abstract][Full Text] [Related]
38. Genomic organization and embryonic expression of miR-430 in medaka (Oryzias latipes): insights into the post-transcriptional gene regulation in early development.
Tani S; Kusakabe R; Naruse K; Sakamoto H; Inoue K
Gene; 2010 Jan; 449(1-2):41-9. PubMed ID: 19770025
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs and genomic instability.
Huppi K; Volfovsky N; Mackiewicz M; Runfola T; Jones TL; Martin SE; Stephens R; Caplen NJ
Semin Cancer Biol; 2007 Feb; 17(1):65-73. PubMed ID: 17113784
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of microRNAs in cancer: playing with fire.
Melo SA; Esteller M
FEBS Lett; 2011 Jul; 585(13):2087-99. PubMed ID: 20708002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
